What Cancer
Can and Can't do
App of the week
Stupid Cancer Peer to Peer App ...
Stupid Cancer's mobile app connects you to a network of peers who understand what you're going through. They've been there, too. You have a right to  ...more
Thursday, September 29, 2022
Survey finds alarming number of young women have no plans of getting mammograms
SEPTEMBER 28, 2022
by Orlando Health

Although recent guidelines state women at average risk should start mammograms at age 40, a new national survey by Orlando Health finds over a fifth of women aged 35-44 have no plans of getting one. Credit: Orlando Health

About 42,000 women die of breast cancer each year, and while strides are being made in medical treatment  ...more
Thursday, September 29, 2022
Heart disease prevention is particularly important in cancer patients
SEPTEMBER 26, 2022
by Johannes Angerer, Medical University of Vienna

Heart disease prevention is particularly important in cancer patients
Baseline cardiovascular toxicity risk assessment checklist. BNP, B-type natriuretic peptide; cTn, cardiac troponin; CTR-CVT, cancer therapy-related cardiovascular toxicity; CV, cardiovascular; CVD, CV disease; CVRF, cardiovascul  ...more
Thursday, September 29, 2022
Shape-shifting fat cells fuel breast cancer growth
SEPTEMBER 23, 2022
by UT Southwestern Medical Center

Fat cells (shown in red) take on a new form (green) as they come in contact with a tumor (blue). Credit: UT Southwestern Medical Center
Fat cells, or adipocytes, that grow in close proximity to breast cancers can shift into other cell types that promote tumor growth, a new study by UT Southwestern researchers s  ...more
Thursday, September 29, 2022
Active surveillance feasible for low-risk thyroid cancer
SEPTEMBER 22, 2022

Active surveillance may be a viable strategy for most diagnosed thyroid cancers, according to a study published online on Sept. 15 in JAMA Oncology.

Allen S. Ho, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues followed 222 patients with =20-mm Bethesda 5 to 6 thyroid nodules who selected treatment with either active surve  ...more
Thursday, September 29, 2022
Ryan Reynolds has urged 45-year-olds to screen for bowel cancer. But the case for screening in your 40s isn't clear cut
SEPTEMBER 21, 2022
by Katy Bell and Paul Glasziou, The Conversation

Older Australians are asked to test every two years. Credit: Shutterstock
Last week, actors Ryan Reynolds and Rob McElhenney released a video of themselves getting colonoscopies to encourage others to undergo screening. The procedure detected polyps in the two men, both aged 45.

Last year, the  ...more
Thursday, September 29, 2022
Cancer in those under 50 is rising, globally. Why?
SEPTEMBER 20, 2022
by Siobhan Glavey, The Conversation

Gut bacteria are changed by a high-sugar diet. Credit: Oleksandra Naumenko/Shutterstock
We know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose weight and get enough sleep. But what if much of what causes cancer has already happened i  ...more
Thursday, September 29, 2022
Drug resistance is a powerful menace in certain breast and ovarian cancers. Now scientists are figuring out why
by Delthia Ricks, Medical Xpress

Just as bacteria, viruses, and fungi develop strategies to outsmart antimicrobial medications, cancer cells can become resistant to chemotherapy. And among tumors, those associated with triple-negative breast cancer and ovarian tumors can develop a powerful form of resistance.

In an intriguing line of   ...more
Thursday, September 29, 2022
Breast cancer findings 'suggest a new set of criteria for avoiding radiation'
SEPTEMBER 16, 2022
by Maureen Salamon, Harvard Medical School

Women diagnosed with early-stage breast cancer often can choose to have a lumpectomy, which removes only cancerous tissue and a thin margin of surrounding healthy cells instead of the entire breast. Current cancer guidelines for most women under 65 recommend following lumpectomy with radiation therapy,   ...more
Thursday, September 29, 2022
Cost of cancer treatment can impact health of survivors
SEPTEMBER 15, 2022
by Medical College of Georgia at Augusta University

A significant number of people who have survived cancer are living in poverty, which can have negative effects on their physical and mental health, according to researchers at the Medical College of Georgia and the Georgia Cancer Center at Augusta University.

Using the Centers for Diseas  ...more
Thursday, September 29, 2022
Out-of-pocket costs for cancer care keep climbing
SEPTEMBER 14, 2022
Out-of-pocket costs for cancer care keep climbing
Cancer patients already have a lot to deal with emotionally and physically. But research shows that insured patients under 65 are also paying more for their treatments out-of-pocket than ever before.

The study highlights the "growing financial burden for non-elderly patients with cancer with pri  ...more
Tuesday, September 13, 2022
Study of cancer immunotherapy patients reveals markers of treatment response
SEPTEMBER 13, 2022

by Allessandra DiCorato, Broad Institute of MIT and Harvard

The treatment of blood cancers has dramatically improved in the last five years, thanks to a new class of cancer immunotherapies called CAR-T cell therapy. This therapy—which involves engineering a patient's own T cells in the lab to kill cancer cells and then infusing them back into   ...more
Tuesday, September 13, 2022
Quantitative pathologic analysis may help predict prognosis in colorectal cancer
SEPTEMBER 12, 2022

Quantitative pathologic analysis may help predict prognosis in CRC
The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 in Gastroenterology.

Reetesh K. Pai, M.D., from the University of Pittsburgh Medical Center, and colleagues appl  ...more
Tuesday, September 13, 2022
T cells that 'nibble' tumors unwittingly help cancer evade the immune response
SEPTEMBER 10, 2022
by University of Pennsylvania

The immune system is equipped to respond not just to external invaders—think viruses, bacteria, and parasites—but also to internal threats, namely, cancer. Yet, frequently, malignancies overcome the immune system's defenses and evade detection.

In a new study, researchers led by Serge Y. Fuchs of the School of   ...more
Tuesday, September 13, 2022
Breaking down proteins: How starving cancer cells switch food sources
by German Cancer Research Center

Cancer cells often grow in environments that are low in nutrients, and they cope with this challenge by switching their metabolism to using proteins as alternative "food". Building on genetic screens, an international team of scientists could identify the protein LYSET as part of a pathway that allows cancer cells  ...more
Friday, September 9, 2022
Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood
by Weizmann Institute of Science

Blood tests—simple, noninvasive and economically feasible—promise to become the next major milestone in cancer diagnosis. However, most of these tests, dubbed liquid biopsies, are currently not reliable enough for widespread use. A new, multiparameter approach developed at the Weizmann Institute of Science may lea  ...more
Friday, September 9, 2022
Patients with some forms of aggressive esophageal cancers may benefit from treatment targeting how cells self-regulate
by Case Western Reserve University

Research led by Case Western Reserve University has identified a promising path to developing therapies to treat esophageal tumors––a form of cancer that not only is among the most deadly, but also has been occurring at increasing rates over the past decade.

The team of researchers from the School of Medicine  ...more
Friday, September 9, 2022
Cancers in adults under 50 are on the rise globally
by Brigham and Women's Hospital

Over recent decades, more and more adults under the age of 50 are developing cancer. A study conducted by researchers from Brigham and Women's Hospital reveals that the incidence of early onset cancers (those diagnosed before age 50), including cancers of the breast, colon, esophagus, kidney, liver, and pancreas am  ...more
Tuesday, September 6, 2022
Researchers suggest it's time for updated warning labels on alcoholic beverages
September 6, 2022 Report
by Bob Yirka , Medical Xpress

A pair of researchers, one with the Harvard T.H. Chan School of Public Health, the other with the University of North Carolina, Chapel Hill, are suggesting that it is time to update the warning labels that appear on bottles and cans containing alcohol-based beverages made for sale to the public. In their paper  ...more
Tuesday, September 6, 2022
Using machine learning to identify undiagnosable cancers
by Bendta Schroeder, Massachusetts Institute of Technology

“Machine learning tools like this one could empower oncologists to choose more effective treatments and give more guidance to their patients,” says Koch Institute clinical investigator Salil Garg. Credit: Massachusetts Institute of Technology

The first step in choosing the appropriate   ...more
Tuesday, September 6, 2022
Researchers report encouraging immunotherapy option for relapsed myeloma patients
by The Mount Sinai Hospital

Mount Sinai researchers report encouraging immunotherapy option for relapsed myeloma patients

Treatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb clinical trial at Mount Sinai Hospital. Out of those 115 pat  ...more
Thursday, September 1, 2022
Leukemia drug shows potential against metastatic HER2-positive breast cancer
AUGUST 31, 2022
by Sarah Avery, Duke University

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

The finding, appearing online on Aug. 30 in the journal Cell Reports, provides evidence for human trials and suggests   ...more
Thursday, September 1, 2022
Epidemiological studies on gastroesophageal reflux disease and esophageal cancer
by Karolinska Institutet

Esophageal cancer is the seventh most common cancer worldwide and a lethal malignancy causing a considerably high number of deaths. There is currently no promising method for prevention, early detection, or screening of esophageal cancer so most patients are diagnosed at an advanced stage, which is associated with a poor prognosis.

The mos  ...more
Thursday, September 1, 2022
Therapeutic viruses help turbocharge the immune system against cancer
AUGUST 27, 2022
by Richard Harth, Arizona State University

Therapeutic viruses help turbocharge the immune system against cancer
The illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how a combination of immunotherapy and virotherapy, using the myxoma virus, provides new  ...more
Thursday, September 1, 2022
Differences found in how doctors, caregivers, and patients report side effects of cancer therapy
AUGUST 26, 2022
by Children's Hospital Los Angeles

A recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. Doctors often underestimate or miss a child's symptoms, while caregivers tend to overestimate symptoms.

Children's Hospital Los Angeles was one of nine hospitals that participated i  ...more
Thursday, September 1, 2022
Neurofeedback shows promise for addressing 'chemo brain' in pilot study
AUGUST 25, 2022
by University of California, Los Angeles

Restoring normal functioning in the brains of cancer patients through neurofeedback could potentially alleviate the mental fogginess that many report after treatment, according to a new pilot study from UCLA researchers.

The study is one of the first to indicate that neurofeedback, or electroencephalogr  ...more
Thursday, September 1, 2022
New chemical technology leads to better-targeted therapeutics against high-risk leukemia in lab
AUGUST 24, 2022
by St. Jude Children's Research Hospital

More-effective therapies are greatly needed for children with high-risk blood cancer T-cell acute lymphoblastic leukemia (T-ALL). St. Jude Children's Research Hospital scientists have leveraged the latest chemical technology called proteolysis targeting chimera (PROTAC) to develop a drug for these patients.   ...more
Thursday, September 1, 2022
Long-term benefit of radiotherapy confirmed in advanced prostate cancer
AUGUST 23, 2022
by Institute of Cancer Research

Long-term benefit of radiotherapy confirmed in advanced prostate cancer
Treated prostate cancer cells. Credit: Mateus Crespo/Professor Johann de Bono, the ICR
Radiotherapy to the prostate alongside standard treatment can keep some men with advanced prostate cancer alive for longer without detriment to the quality of   ...more
Thursday, September 1, 2022
Understanding why deadly brain cancer comes back
AUGUST 22, 2022
by University of Leeds

The deadliest form of brain cancer returns because tumors adapt to treatment by recruiting help from nearby healthy tissue, say researchers who are trying to find a cure for the disease.

A new study, by a global team including University of Leeds experts, has found that in response to treatment, high-grade gliomas appear t  ...more
Thursday, September 1, 2022
Tobacco, alcohol are main causes of cancer worldwide: Study

Nearly half of cancers worldwide can be traced back to a known risk factor, primarily tobacco or alcohol, a huge global study found on Friday, which said that behavioral changes can help reduce the threat of disease.

The study—published in The Lancet and conducted as part of a vast research program funded by the Bill Gates Foundation—concluded that 44.4 percent o  ...more
Monday, July 18, 2022
Prognosis of cancer patients improved through significant discovery
JULY 18, 2022
by Umea University

Prostate cancer is the most common form of cancer in males in Sweden. Researchers at Umeå University have now discovered a faster and easier way to determine who has an aggressive form of cancer and who does not.

"This may have great implications on precision medicine when treating prostate cancer, and on more cancer groups alik  ...more